More




Wishing You a very Beautiful Tuesday

Get to know the fact, and the fact itself will set you free!





Fourth Large-scale COVID-19 Vaccine Trial Begins in the United States

Informed 3 weeks ago

A fourth Phase 3 clinical trial evaluating an investigational vaccine for coronavirus disease 2019 (COVID-19) has begun enrolling adult volunteers. The trial is designed to evaluate if the investigational Janssen COVID-19 vaccine (JNJ-78436725) can prevent symptomatic COVID-19 after a single dose regimen. Up to 60,000 volunteers will be enrolled in the trial at up to nearly 215 clinical research sites in the United States and internationally. The Janssen Pharmaceutical Companies of Johnson & Johnson developed the investigational vaccine (also known as Ad.26.COV2.S) and is leading the clinical trial as regulatory sponsor.


Source:  Johns Hopkins Center for Health Security (National Institutes of Health)





ONLINE E-BOOKS


Online E-books, Textbooks and related materials.